| Name | Title | Contact Details |
|---|
Unlike traditional approaches that only address symptoms, Cardionomic addresses the conditions root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality. This breakthrough therapy is also expected to increase pharmacological tolerance at discharge, which will reduce costly readmission and extend life. Spun off from Denali Medical II, a New Enterprise Associates (NEA) backed incubator, Cardionomic is funded by NEA, Greatbatch Medical and Cleveland Clinic Foundation.
Evans Analytical Group (EAG) has been a global leader in surface analysis and materials characterization for over 29 years, delivering innovative analytical services and solutions with uncompromising scientific integrity.
Crittenton Hospital Medical Center is dedicated to enhancing the health status of the individuals that it serves.
Genoa Healthcare operates on a simple premise: On-site pharmacies are better for patients - and the mental health clinics that serve them.
Amanna Health Institute is a Alpena, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.